GlobeNewswire
DIAGNOS Announces Grant of Stock Options
BROSSARD, Quebec, Feb. 10, 2023 (GLOBE NEWSWIRE) — February 10, 2023 – Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the grant of an aggregate number of 1,275,000 stock options to its officers, employees, consultants and directors. Stock options vest at 50% per year, commencing with the first anniversary of the grant. Th